Latest Interviews
Showing 436–450 of 1,205 transcripts.
Clear all filters- Milken Institute56 min
Shifting Tides: A Macroeconomic Outlook
John Defterios, Virginie Afota, Roxanne Davies, Robert A. Gillam, Michael Metcalfe, Alireza Zaimi, Rob, Virginia, Ella Reyes, Brigitte
This macroeconomic forum analyzed how central bank liquidity and media narratives are currently driving asset rallies while emerging markets like China face GDP contraction from trade tensions and viral shocks. Experts contrasted these short-term credit risks with long-term structural themes, including a projected 20% global population growth and the strategic evolution of sovereign wealth funds in the Middle East toward diversified infrastructure and ESG integration. The panel concluded that despite volatile oil prices and inflation concerns, institutional investors are increasingly shifting from tactical trading to decade-long horizons focused on demographic shifts, technological disruption, and sustainable resource allocation in Asia and emerging economies.
- Milken Institute1h 2m
Is Crypto Finally Growing Up?
Staci Warden, Michael Gronager, Navin Gupta, George Kikvadze, Simon Seojoon Kim, Mike Novogratz
Moderated by Stacey Worden, a panel of industry leaders including Mike Novogratz and George Kikvadze confirmed the cryptocurrency sector's evolution from a speculative frontier to a regulated, institutional-grade asset class. The discussion highlighted Bitcoin's role as a macro hedge against fiat debasement while outlining how enterprise solutions like Ripple are driving mass adoption in Asia and how blockchain traceability effectively combats illicit finance. Looking ahead, the group projected that infrastructure maturation over the next five years will trigger a global economic transformation comparable to the post-1999 internet boom, with billions of users entering the ecosystem through decentralized finance and device-to-device interactions.
- Milken Institute50 min
Life After Sport - What Do Elite Atheltes Do Next?
Sarah Sandler, Khaled Al-Mahri, Didier Drogba, Clarence Seedorf, Vladimir Kilichkov
Hosted by the Milken Institute in Abu Dhabi, an all-star panel featuring Didier Drogba, Nicolas Anelka, Clarence Seedorf, and Vladimir Kilichkov discussed strategic transitions from elite athletics to sustainable business and leadership roles under the moderation of Khaled Al-Mahri. The distinguished athletes shared specific insights on mental resilience, injury prevention, and long-term planning, while highlighting critical gaps in African football infrastructure and the broader socio-political power of the sport. Their collective dialogue emphasized that enduring success in both sports and commerce requires a foundational philosophy of "Challenge Management," coordinated efforts among strategic partners, and a shift toward proactive, future-oriented governance.
- Milken Institute59 min
Private Equity: A Continuing Evolution of Capital Access
Glen August, Nazim Azimbaev, Maggie Finari, Ray Thorne, Andrew Weinberg, Mark O'Lean
Leading institutional investors including Glen August of Oak Hill Advisors and Maggie Finari of Ontario Teachers' Pension Plan convened to debate strategies for securing 20% net returns in a private market increasingly constrained by 11–12% historical averages. The panelists outlined divergent approaches ranging from Ray Thorne's asset-intensive company building to Andrew Weinberg's focus on the middle-market family business wealth transfer, all while integrating ESG principles and data science to hedge against technological disruption. Despite optimistic targets, the group emphasized that geopolitical tensions, potential policy shifts, and the inevitable credit cycle downturn necessitate strict covenant protections and selective operational value-add to sustain performance.
- Milken Institute57 min
Being the Disruptor, Not the Disrupted
Dana Hamilton, Joe Sitz, Jonathan, Hussein
Real estate leaders are being compelled to disrupt traditional models by aligning capital with megatrends in technology, demographics, and flexible workspaces to navigate the volatility of global gateway cities. Industry players like the Kean Group and Pretium are pivoting toward data-driven value creation, shifting from vanilla office assets to specialized logistics, biotech, and experiential wellness environments that cater to the "time-poor" consumer. While aggressive digital transformation and strategic brand licensing offer competitive advantages, successful execution now demands resilient funding structures capable of withstanding black swan events and rapidly adapting to regulatory lag.
- Milken Institute37 min
Opening Plenary - Part 2: Global Overview
Waleed Al Muhairi, Adam Boehler, Raymond Dalio, Dina Powell McCormick, John, Haldun al-Mubarak
The event analyzes escalating global economic headwinds driven by geopolitical tensions and the coronavirus outbreak while detailing how major institutional investors like Mubadala adjust their portfolios toward cash-flow robust assets amidst shifting monetary policies. Simultaneously, the discussion highlights the strategic maneuvering of entities such as the DFC to counter Chinese influence in emerging markets and addresses the urgent need for economic diversification in the Middle East to mitigate youth unemployment risks. Experts emphasize that long-term success now depends on integrating ESG principles and accelerating the transition away from hydrocarbon dependency before fiscal stability is compromised by resource depletion.
- Milken Institute47 min
Wednesday Lunch: Walking the Drug-Pricing Tightrope
Dan Diamond, Dan Leonard, Seema Verma, Matt Iles, Mark McClellan
Moderated by Dan Diamond, the Milken Institute's Future of Health Summit panel "Walking the Drug Pricing Tightrope" featured Seema Verma, Matt Iles, and Mark McClellan debating the tension between innovation and affordability amidst record-breaking drug costs. While the group reached consensus on shifting to value-based payment models to address unsustainable spending in Part B and high-cost curative therapies, they diverged on whether government negotiation or private sector competition offers the most effective solution for lowering prices without stifling future research. With Nancy Pelosi absent, the panelists emphasized that any viable legislative path must satisfy strict bipartisanship requirements to avoid jeopardizing patient access or long-term drug development pipelines.
- Milken Institute57 min
Sexual, Reproductive, and Maternal Health in America
Christy Turlington Burns, Dr. Michael Liu, Dr. Lena Nguyen, Representative Lauren Underwood
In a session featuring Dr. Michael Liu, Christy Turlington Burns, Dr. Lena Nguyen, and Rep. Lauren Underwood, experts addressed the 50% rise in U.S. maternal mortality and the threefold racial disparity that leaves over 700 women dead annually. The panel detailed recent legislative victories by the Black Maternal Health Caucus, including $50 million in funding and a push for 12-month postpartum Medicaid coverage, while emphasizing that half of these deaths are preventable through safety bundles and bias training. Despite concerns about technology exacerbating inequities, the speakers advocated for high-touch care models and systemic reforms targeting social determinants to secure bipartisan support for maternal survival.
- Milken Institute58 min
Poised to Break the Bank: Paying for Chronic Disease
Allison, Anand, Tom, Nancy, Paul Davis, Eric, Michael Golinkoff, John Rother, Megan Golden, Jess Leifer, Stephanie Cousins
A multi-sector consensus addresses the $2.4 trillion annual burden of chronic U.S. diseases by implementing interventions like Geisinger's Food Pharmacy, which reduces healthcare costs by aligning patient acuity with intensive lifestyle support. While capitated payment models and digital innovations such as Omada Health improve scalability and outcomes, structural barriers including payer misalignment and low screening rates for prediabetes necessitate policy shifts toward sugar taxes and multi-payer funding. Concurrently, the medical landscape is pivoting from opioid reliance to holistic pain management and gene therapies, with academic institutions like Kaiser Permanente adapting curricula to prioritize prevention and address the mental health needs of 74% of employees.
- Milken Institute58 min
Gun Violence as a Public Health Crisis
Ed, Dan Diamond, Dr. Megan Ranney, Dr. Babak Sarani, Lina Wen, Dr. Mallory Williams, Maya, Chris Corey, Kenyatta Hazelwood, Josh, Bob
A panel of medical professionals and public health experts advocates for a public health approach to gun violence, emphasizing that current political narratives often overlook evidence-based solutions like high-capacity magazine restrictions in favor of ineffective symbolic measures. The discussion highlights a severe research drought caused by federal inaction since 1996, while profiling successful local interventions such as Baltimore's Safe Streets program and urging the integration of trauma centers into long-term community conflict resolution. Despite broad optimism for shifting discourse, the panelists warn that sustained progress remains contingent on overcoming funding gaps and addressing the social determinants of health that disproportionately impact minority communities.
- Milken Institute1h 16m
Reducing the Cost and Risk of Dementia
Nora Super, Michael Belleville, Jennie Chin Hansen, Kevin Crain, Jeff Huber, Shari Ling, Sarah Locke, Ian Cramer, Orion, Alan Stevens, Jill Lesser
The Milken Institute's new report on reducing dementia costs sparked a multi-sector dialogue involving CMS officials, patient advocates, and industry leaders to address critical gaps in workforce preparedness and community support. Key initiatives highlighted include CMS's expanded billing codes for cognitive screening, the rapid growth of accredited Geriatric Emergency Departments that reduce hospitalizations, and innovative financial strategies to protect caregivers from retirement disparities. Panelists emphasized that effective intervention requires moving beyond isolated medical treatment to holistic models that integrate home care, fraud detection, and policy changes aimed at improving long-term quality of life.
- Milken Institute59 min
Age-Forward 2030: The Intersection of Housing and Health Care
Susan Donley, Gretchen Alkema, Bechara Choucair, Tama Duffy Day, Christopher Herbert, Susan Donnelly
Driven by the urgent reality that half of middle-income seniors cannot afford both housing and care, this event convenes policymakers, healthcare leaders, and urban planners to address the rising demographic of adults over 80 who face severe social isolation and financial insecurity. The discussion highlights successful cross-sector initiatives, such as California's "Master Plan for Aging" and intergenerational housing models, which integrate affordable housing with health services to reduce costly hospitalizations and extend life expectancy. Participants outline a 2030 vision requiring federal and local governments to dismantle policy silos, reform zoning laws, and invest $200 million or more to create stable, age-friendly communities that leverage older adults as active societal contributors.
- Milken Institute58 min
Gut Feeling: Food, Microbiome, and Disease Prevention
Julie DiBiase, Robynne Chutkan, Rob Knight, David Perlmutter, Karen Sandell Sfanos, Robin Chutkan, Mark Hyman
Leading experts in functional medicine and microbiome research convened to establish that diet and environmental exposure fundamentally dictate human health by shaping the trillions of symbiotic microbes governing metabolism and immunity. Their discussions highlighted critical interventions, ranging from plant-rich dietary protocols that promote beneficial bacteria like *Akkermansia* to germ-free animal studies proving that specific microbial strains can transmit diseases such as cancer and autoimmune disorders. Ultimately, the panel advocates for a shift toward personalized medicine that utilizes longitudinal microbiome data and holistic lifestyle changes to prevent chronic illness rather than relying on transient pharmaceutical fixes.
- Milken Institute1h 0m
The Business Case for Addressing Social Determinants of Health
Joanne Kenen, Georges Benjamin, Thomas Moriarty, Ashley Perry, Lauren Shweder Biel, Emily Yu, Joanne Cannon, Lauren Schwader-Beal, Katherine Connelly, Michael Golinkoff
Moderated by Joanne Cannon, a panel of public health leaders and corporate strategists redefined the conversation around Social Determinants of Health by prioritizing the business case for intervention over traditional philanthropy. Speakers detailed scalable models such as DC Greens' produce prescription program and CVS's integrated health hubs, which leverage data-driven insights to prove cost savings through medication compliance and reduced emergency room visits. The group concluded that sustainable growth depends on transitioning funding from grants to payer reimbursement within value-based care systems, leveraging political and corporate influence to address root causes like housing instability.
- Milken Institute1h 1m
Opioid Addiction: A Crisis Fueled by Stigma
Robert Redfield, Sarah Carlin-Smith, Dr. Kelly Clark, Gary Mendel, Dr. Andrei Ostrovsky, Jerome Adams, Ronnie Solomon, Michael Golinkoff
A collaborative panel led by Surgeon General officials and researchers from Shatterproof and McKinsey identifies stigma as the primary barrier in the opioid crisis, highlighting how it drives public misunderstanding, provider bias, and critical gaps in Medicaid and federal funding. The group outlines a strategic shift toward humanizing recovery narratives, integrating addiction care into chronic disease management frameworks, and utilizing settlement funds for evidence-based programs to reduce overdose mortality by 50%. By advocating for the removal of restrictive privacy laws like 42 CFR Part 2 and the elimination of the X-waiver, the initiative seeks to dismantle systemic prejudices that currently prevent 60% of treatment facilities from offering FDA-approved medications.